Renal impairment as a possible side effect of gabapentin

Neuropsychobiology

Volumn 38, Issue 3, 1998, Pages 198-199

  Grunze, Heinz ^a,c   Dittert, Sebastian ^a   Bungert, Martina ^b   Erfurth, Andreas ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Bezirkskrankenhaus Kempten ^*  (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Bipolar disorder; Creatinine; Gabapentin; Mania; Renal; Side effects

Indexed keywords

CLONAZEPAM; CREATININE; GABAPENTIN; PERAZINE;

ADULT; CASE REPORT; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION TEST; MALE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL;

ACETIC ACIDS; ADULT; AMINES; ANTIMANIC AGENTS; BIPOLAR DISORDER; CYCLOHEXANECARBOXYLIC ACIDS; DRUG THERAPY, COMBINATION; GAMMA-AMINOBUTYRIC ACID; HUMANS; KIDNEY DISEASES; MALE;

EID: 0031756894     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026537     Document Type: Conference Paper

References (5)

1. Erfurth A, Kammerer C, Grunze H. Normann C, Walden J: An open label sludy of gabapentin in the treatment of mania. J Psychiatr Res 1998: in press.
2. Dichter MA. Brodic J: New antiepileptic drugs. N Engl J Med 1996;334:1583 1590.
3. Beydoun A, Uthman BM, Sackellares JC: Gabapentin: Pharmacokineties, effiicacy, and safety. Clin Neuropharmacol 1995;18:469-481.
4. Bech P, Rafaelsen OJ, Kramp P, Bolwing TG: The mania rating scale: Scale construction and inter-observer agreement. Neuropharmacology 1978;17:430-431.
5. Blum RA, Comstock TJ, Sica DA, Schultz RW, Keller E, Reetze P, Bockbrader H, Tuerck D, Busch JA, Recce PA, Sedman AJ: Pharmacokinetics of gabapentin in subjects with various degrees of renal function. Clin Pharmacol Ther 1994;56:154-159.